By
Drug Target Review2023-10-11T16:00:21
New research uncovers how neutrophils trigger cellular processes to counteract the Candida albicans toxin.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-11T12:59:00Z
2026-04-24T07:00:00Z
2026-03-31T14:05:00Z
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-07-11T16:13:06
Sponsored by Agilent
Site powered by Webvision Cloud